Literature DB >> 19259806

Effect of antioxidant treatment in global ischemia and ischemic postconditioning in the rat hippocampus.

Iveta Domoráková1, Eva Mechírová, Marianna Danková, Viera Danielisová, Jozef Burda.   

Abstract

Ischemic postconditioning is a very effective way how to prevent delayed neuronal death. Effect of Ginkgo biloba extract (EGb 761; 40 mg/kg) posttreatment was studied on the rat model of transient forebrain ischemia and ischemia/postconditioning. Global ischemia was produced by four-vessel occlusion in Wistar male rats. Two experimental protocols were used: (a) 10 min of ischemia/7 days of reperfusion with or without EGb 761 treatment or (b) 10 min of ischemia/2 days of reperfusion/5 min of ischemia (postconditioning), following 5 days of reperfusion. EGb 761 was applied as follows: 30 min before 10 min of ischemia then 5 h, 1 and 2 days after 10 min of ischemia. Fluoro Jade B, marker for neuronal degeneration, was used for quantitative analysis of the most vulnerable hippocampal CA1 neurons. Cognitive and memory functions were tested by Morris water maze, as well. Administration of EGb 761 30 min before 10 min of ischemia or 5 h after ischemia has rather no protective effect on neuronal survival in CA1 region. Ten minutes of ischemia following ischemic postconditioning after 2 days of reperfusion trigger a significant neuroprotection of CA1 neurons, but it is abolished by EGb 761 posttreatment. Ischemia/postconditioning group showed a significant improvement of learning and memory on the seventh day of reperfusion. Protection of the most vulnerable CA1 neurons after ischemia/postconditioning is abolished by exogenous antioxidant treatment used in different time intervals after initial ischemia. Moreover, combination of EGb 761 administration with repeated stress (5 min ischemia used as postconditioning) causes cumulative injury of CA1 neurons.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19259806     DOI: 10.1007/s10571-009-9365-7

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  38 in total

1.  Ginkgo biloba extract EGb 761 increases stress resistance and extends life span of Caenorhabditis elegans.

Authors:  Zhixin Wu; Julie V Smith; Vijayakumar Paramasivam; Peter Butko; Ikhlas Khan; James R Cypser; Yuan Luo
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2002-09       Impact factor: 1.770

2.  Rapid preconditioning protects rats against ischemic neuronal damage after 3 but not 7 days of reperfusion following global cerebral ischemia.

Authors:  M A Pérez-Pinzón; G P Xu; W D Dietrich; M Rosenthal; T J Sick
Journal:  J Cereb Blood Flow Metab       Date:  1997-02       Impact factor: 6.200

3.  Evidence for a role of second pathophysiological stress in prevention of delayed neuronal death in the hippocampal CA1 region.

Authors:  Jozef Burda; Milina Matiasová; Miroslav Gottlieb; Viera Danielisová; Miroslava Némethová; Lidia Garcia; Matilde Salinas; Rastislav Burda
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

4.  A new model of bilateral hemispheric ischemia in the unanesthetized rat.

Authors:  W A Pulsinelli; J B Brierley
Journal:  Stroke       Date:  1979 May-Jun       Impact factor: 7.914

5.  The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid.

Authors:  S Bastianetto; C Ramassamy; S Doré; Y Christen; J Poirier; R Quirion
Journal:  Eur J Neurosci       Date:  2000-06       Impact factor: 3.386

6.  Role of protein synthesis in the ischemic tolerance acquisition induced by transient forebrain ischemia in the rat.

Authors:  Jozef Burda; Milina Hrehorovská; Lidia García Bonilla; Viera Danielisová; Dása Cízková; Rastislav Burda; Miroslava Némethová; Juan L Fando; Matilde Salinas
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

7.  Hyperbaric oxygen preconditioning induces tolerance against brain ischemia-reperfusion injury by upregulation of antioxidant enzymes in rats.

Authors:  Jiasi Li; Wenwu Liu; Suju Ding; Weigang Xu; Yangtai Guan; John H Zhang; Xuejun Sun
Journal:  Brain Res       Date:  2008-03-12       Impact factor: 3.252

8.  Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761.

Authors:  Yuan Luo; Julie V Smith; Vijaykumar Paramasivam; Adam Burdick; Kenneth J Curry; Justin P Buford; Ikhlas Khan; William J Netzer; Huaxi Xu; Peter Butko
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-04       Impact factor: 11.205

9.  Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761.

Authors:  Julie Vining Smith; Yuan Luo
Journal:  J Alzheimers Dis       Date:  2003-08       Impact factor: 4.472

10.  Post-conditioning exacerbates the MnSOD immune-reactivity after experimental cerebral global ischemia and reperfusion in the rat brain hippocampus.

Authors:  Miroslava Nemethova; Viera Danielisova; Miroslav Gottlieb; Jozef Burda
Journal:  Cell Biol Int       Date:  2007-09-07       Impact factor: 3.612

View more
  10 in total

1.  An effective combination of two different methods of postconditioning.

Authors:  Viera Danielisova; Jozef Burda; Miroslava Nemethova; Miroslav Gottlieb; Rastislav Burda
Journal:  Neurochem Res       Date:  2012-06-19       Impact factor: 3.996

2.  Protective effects of a novel synthetic α-lipoic acid-decursinol hybrid compound in experimentally induced transient cerebral ischemia.

Authors:  Tae Hun Lee; Joon Ha Park; Jong-Dai Kim; Jae-Chul Lee; In Hye Kim; Yongbae Yim; Seul Ki Lee; Bing Chun Yan; Ji Hyeon Ahn; Choong Hyun Lee; Ki-Yeon Yoo; Jung Hoon Choi; In Koo Hwang; Jeong Ho Park; Moo-Ho Won
Journal:  Cell Mol Neurobiol       Date:  2012-07-20       Impact factor: 5.046

3.  Intermittent hypoxia preconditioning-induced epileptic tolerance by upregulation of monocarboxylate transporter 4 expression in rat hippocampal astrocytes.

Authors:  Chen Gao; Chao Wang; Bei Liu; Hao Wu; Qianli Yang; Jungong Jin; Huanfa Li; Shan Dong; Guodong Gao; Hua Zhang
Journal:  Neurochem Res       Date:  2014-08-22       Impact factor: 3.996

4.  Identification of Vigilin as a Potential Ischemia Biomarker by Brain Slice-Based Systematic Evolution of Ligands by Exponential Enrichment.

Authors:  Chao Liu; Wei Jiang; Xibin Tian; Peng Yang; Le Xiao; Jianglin Li; Liping Qiu; Haijun Tu; Weihong Tan
Journal:  Anal Chem       Date:  2019-05-01       Impact factor: 6.986

5.  Effect of different mild hypoxia manipulations on kainic acid-induced seizures in the hippocampus of rats.

Authors:  Yang Yang; Jianhua Chen; Li Li; Yusong Gao; Jun Chen; Zhou Fei; Weiping Liu
Journal:  Neurochem Res       Date:  2012-10-12       Impact factor: 3.996

Review 6.  Biological networks in ischemic tolerance - rethinking the approach to clinical conditioning.

Authors:  Josef Anrather; John M Hallenbeck
Journal:  Transl Stroke Res       Date:  2013-02       Impact factor: 6.829

Review 7.  Ischemic tolerance - blessing or curse.

Authors:  J Burda; R Burda
Journal:  Physiol Res       Date:  2021-09-10       Impact factor: 1.881

8.  Oxygen glucose deprivation in rat hippocampal slice cultures results in alterations in carnitine homeostasis and mitochondrial dysfunction.

Authors:  Thomas F Rau; Qing Lu; Shruti Sharma; Xutong Sun; Gregory Leary; Matthew L Beckman; Yali Hou; Mark S Wainwright; Michael Kavanaugh; David J Poulsen; Stephen M Black
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

Review 9.  Current Perspectives on the Beneficial Role of Ginkgo biloba in Neurological and Cerebrovascular Disorders.

Authors:  Kevin M Nash; Zahoor A Shah
Journal:  Integr Med Insights       Date:  2015-11-09

10.  Novel antiepileptic drug lacosamide exerts neuroprotective effects by decreasing glial activation in the hippocampus of a gerbil model of ischemic stroke.

Authors:  Ji Yun Ahn; Bing Chun Yan; Joon Ha Park; Ji Hyeon Ahn; Dae Hwan Lee; In Hye Kim; Jeong-Hwi Cho; Bai Hui Chen; Jae-Chul Lee; Young Shin Cho; Myoung Chul Shin; Jun Hwi Cho; Seongkweon Hong; Moo-Ho Won; Sung Koo Kim
Journal:  Exp Ther Med       Date:  2015-10-13       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.